Back to Search
MARIA THEODOULOU, MD
MD
Medical Oncology Physician
NPI: 1720174055IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
183499(NY)
Education
STATE UNIVERSITY OF NEW YORK AT BUFFALO SCHOOL OF MEDICINE
Class of 1988
Research & Publications (19)
Phase I study of nonpegylated liposomal doxorubicin plus trastuzumab in patients with HER2-positive breast cancer.
PMID 19433391·Clin Breast Cancer·2009
3-trial
Adjuvant chemotherapy in older women with early-stage breast cancer.
PMID 19439741·N Engl J Med·2009
4-observational
The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial.
PMID 19138567·Lancet Neurol·2009
2-rct
Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer.
PMID 18398145·J Clin Oncol·2008
3-trial
A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial).
PMID 18384230·PLoS Med·2008
4-observational
Radiofrequency ablation in the management of liver metastases from breast cancer.
PMID 17885061·AJR Am J Roentgenol·2007
8-other
Pemetrexed in patients with locally advanced or metastatic breast cancer who had received previous anthracycline and taxane treatment: phase II study.
PMID 17239262·Clin Breast Cancer·2006
3-trial
A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy.
PMID 16866685·J Am Geriatr Soc·2006
8-other
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective.
PMID 16541322·Breast Cancer Res Treat·2006
8-other
A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane.
PMID 15899073·Clin Breast Cancer·2005
3-trial
First cluster of vancomycin-resistant Enterococcus faecalis isolates in Cyprus.
PMID 15715722·Clin Microbiol Infect·2005
5-case
Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer.
PMID 15355903·Clin Cancer Res·2004
3-trial
Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments.
PMID 15217939·Clin Cancer Res·2004
3-trial
Cardiac profiles of liposomal anthracyclines: greater cardiac safety versus conventional doxorubicin?
PMID 15139046·Cancer·2004
6-review
Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma.
PMID 11751485·Clin Cancer Res·2001
3-trial
Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification.
PMID 11352950·J Clin Oncol·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 400 PATROON CREEK BLVD, SUITE 1
ALBANY, NY 12206 - Phone
- (518) 489-0044
Quick Facts
- NPI
- 1720174055
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 38
- Publications
- 19
Are you this provider?
Claim Your Profile